HUM vs RNAC
Humana Inc (HUM) versus Cartesian Therapeutics Inc. (RNAC) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported RNAC revenue for 2024-12-31 was $38.9M. Net income was -$77.4M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Not investment advice. Open the HUM and RNAC stock pages for the full models.
Not investment advice.